TP53 and PIK3CA mutations were more prevalent in squamous cell carcinomas than in adenocarcinomas (97.4% vs. 71.2%, P = 0.001; 10.5% vs. 0%, P = 0.011 respectively). The gene discussed is TP53; the disease is squamous cell carcinoma.